Gene · 5818
Papers3,675
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,675
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nonreducing Sugar Scaffold Enables the Development of Immunomodulatory TLR4-specific LPS Mimetics with Picomolar Potency. | Angew Chem Int Ed Engl | 2024 | 38870340 | PubTator, text mining | PubMed |
| Herpes simplex virus spreads rapidly in human foreskin, partly driven by chemokine-induced redistribution of Nectin-1 on keratinocytes. | PLoS Pathog | 2024 | 38857290 | Swiss-Prot, curated | PubMed |
| Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications. | Biomed Pharmacother | 2024 | 38761424 | PubTator, text mining | PubMed |
| High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists. | NPJ Vaccines | 2024 | 38702320 | PubTator, text mining | PubMed |
| The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases. | Biomolecules | 2024 | 38672429 | PubTator, text mining | PubMed |
| Analysis of the Immune Response by Standardized Whole-Blood Stimulation with Metabolism Modulation. | Phenomics | 2024 | 38605904 | PubTator, text mining | PubMed |
| Development of a novel, high-efficacy oncolytic herpes simplex virus type 1 platform equipped with two distinct retargeting modalities. | Mol Ther Oncol | 2024 | 38596302 | PubTator, text mining | PubMed |
| Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer. | Cancer Lett | 2024 | 38556105 | PubTator, text mining | PubMed |
| Chimeric NOD2 Mincle Agonists as Vaccine Adjuvants. | J Med Chem | 2024 | 38507580 | PubTator, text mining | PubMed |
| Glycoproteome-Wide Discovery of Cortical Glycoproteins That May Provide Cognitive Resilience in Older Adults. | Neurology | 2024 | 38502899 | PubTator, text mining | PubMed |
| Towards an integrated understanding of inflammatory pathway influence on hematopoietic stem and progenitor cell differentiation. | Bioessays | 2024 | 38488673 | PubTator, text mining | PubMed |
| A Polymer-Based Antigen Carrier Activates Two Innate Immune Pathways for Adjuvant-Free Subunit Vaccines. | ACS Nano | 2024 | 38478910 | PubTator, text mining | PubMed |
| Downregulation of endogenous nectin1 in human keratinocytes by herpes simplex virus 1 glycoprotein D excludes superinfection but does not affect NK cell function. | J Gen Virol | 2024 | 38471041 | PubTator, text mining | PubMed |
| ITF2357 regulates NF-κB signaling pathway to protect barrier integrity in retinal pigment epithelial cells. | FASEB J | 2024 | 38430220 | PubTator, text mining | PubMed |
| Anti-PD-1 therapy reverses TIGIT+CD226+NK depletion in immunotherapy resistance of hepatocellular carcinoma through PVR/TIGIT pathway. | Int Immunopharmacol | 2024 | 38368771 | PubTator, text mining | PubMed |
| The HIF transcription network exerts innate antiviral activity in neurons and limits brain inflammation. | Cell Rep | 2024 | 38363679 | PubTator, text mining | PubMed |
| The Impact of Pathogens on Sepsis Prevalence and Outcome. | Pathogens | 2024 | 38276162 | PubTator, text mining | PubMed |
| Transferrin Is Up-Regulated by Microbes and Acts as a Negative Regulator of Immunity to Induce Intestinal Immunotolerance. | Research (Wash D C) | 2024 | 38274126 | PubTator, text mining | PubMed |
| Evaluation of the Feasibility of In Vitro Metabolic Interruption of Trimethylamine with Resveratrol Butyrate Esters and Its Purified Monomers. | Molecules | 2024 | 38257342 | PubTator, text mining | PubMed |
| Cell-intrinsic C5a synergizes with Dectin-1 in macrophages to mediate fungal killing. | Proc Natl Acad Sci U S A | 2024 | 38252818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5818/papers?page=10